ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

EPAM Systems shares fall 3.7% after JPMorgan downgrade

Analysts cite North American commercial reorganization and reduced revenue guidance as key headwinds. JPMorgan cuts rating to Neutral with a $120 target.

PA
Priya Anand · Equities & Earnings Desk · 29 Aug 2026 · 11:03 · 1 min read
Share
EPAM Systems shares fall 3.7% after JPMorgan downgrade

EPAM Systems fell 3.7% in mid-day trading after JPMorgan downgraded the stock to Neutral from Overweight, citing commercial reorganization in North America as a near-term drag on revenue growth and margins.

The analyst maintained a $120 price target, reflecting concerns that the reorganization will take time to yield returns amid a challenging environment for digital IT services. William Blair similarly downgraded EPAM to Market Perform, citing sustained pressure in North America, while Guggenheim reduced its price target to $140 from $165 but retained a Buy rating.

The downgrades followed EPAM’s second-quarter 2026 earnings report in early August, during which the company lowered its full-year revenue growth outlook to a range of 3.2%–4.2% and guided for only modest top-line expansion in the third quarter. The reduced guidance underscored broader challenges in the digital IT services sector, compounded by softer demand in North America.

A partnership with cloud security firm Wiz, announced the prior day and now part of Google Cloud, provided a modest strategic boost but failed to offset the selling pressure. The broader market also weighed on sentiment, with the S&P 500 down 0.1%, the Dow Jones down 0.2%, and the Nasdaq down 0.3% during the session.

EPAM’s stock has traded between a 52-week high of $222.53 and a low of $73.06.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT